Logo image of PHIA.AS

KONINKLIJKE PHILIPS NV (PHIA.AS) Stock Fundamental Analysis

AMS:PHIA - Euronext Amsterdam - NL0000009538 - Common Stock - Currency: EUR

25.61  -0.01 (-0.04%)

Fundamental Rating

3

Taking everything into account, PHIA scores 3 out of 10 in our fundamental rating. PHIA was compared to 55 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of PHIA have multiple concerns. PHIA has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

PHIA had positive earnings in the past year.
PHIA had a positive operating cash flow in the past year.
In multiple years PHIA reported negative net income over the last 5 years.
Of the past 5 years PHIA 4 years had a positive operating cash flow.
PHIA.AS Yearly Net Income VS EBIT VS OCF VS FCFPHIA.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B

1.2 Ratios

Looking at the Return On Assets, with a value of -1.43%, PHIA is doing worse than 60.78% of the companies in the same industry.
PHIA has a worse Return On Equity (-3.54%) than 60.78% of its industry peers.
Industry RankSector Rank
ROA -1.43%
ROE -3.54%
ROIC N/A
ROA(3y)1.3%
ROA(5y)2.5%
ROE(3y)2.33%
ROE(5y)5.25%
ROIC(3y)N/A
ROIC(5y)N/A
PHIA.AS Yearly ROA, ROE, ROICPHIA.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20

1.3 Margins

PHIA's Operating Margin has declined in the last couple of years.
PHIA has a worse Gross Margin (41.56%) than 70.59% of its industry peers.
In the last couple of years the Gross Margin of PHIA has remained more or less at the same level.
PHIA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.56%
OM growth 3Y-40.52%
OM growth 5Y-26.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.47%
GM growth 5Y-1.32%
PHIA.AS Yearly Profit, Operating, Gross MarginsPHIA.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30 40

More info and screens

2

2. Health

2.1 Basic Checks

PHIA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PHIA has less shares outstanding
Compared to 5 years ago, PHIA has more shares outstanding
Compared to 1 year ago, PHIA has a worse debt to assets ratio.
PHIA.AS Yearly Shares OutstandingPHIA.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M
PHIA.AS Yearly Total Debt VS Total AssetsPHIA.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B

2.2 Solvency

PHIA has an Altman-Z score of 1.64. This is a bad value and indicates that PHIA is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.64, PHIA perfoms like the industry average, outperforming 43.14% of the companies in the same industry.
PHIA has a debt to FCF ratio of 7.27. This is a slightly negative value and a sign of low solvency as PHIA would need 7.27 years to pay back of all of its debts.
PHIA has a Debt to FCF ratio (7.27) which is in line with its industry peers.
A Debt/Equity ratio of 0.60 indicates that PHIA is somewhat dependend on debt financing.
PHIA has a Debt to Equity ratio of 0.60. This is in the lower half of the industry: PHIA underperforms 68.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 7.27
Altman-Z 1.64
ROIC/WACCN/A
WACC6.03%
PHIA.AS Yearly LT Debt VS Equity VS FCFPHIA.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5B 10B

2.3 Liquidity

PHIA has a Current Ratio of 1.16. This is a normal value and indicates that PHIA is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of PHIA (1.16) is worse than 74.51% of its industry peers.
A Quick Ratio of 0.74 indicates that PHIA may have some problems paying its short term obligations.
PHIA has a Quick ratio of 0.74. This is in the lower half of the industry: PHIA underperforms 68.63% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 0.74
PHIA.AS Yearly Current Assets VS Current LiabilitesPHIA.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.65% over the past year.
Measured over the past years, PHIA shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.67% on average per year.
PHIA shows a decrease in Revenue. In the last year, the revenue decreased by -2.65%.
PHIA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.05% yearly.
EPS 1Y (TTM)3.65%
EPS 3Y-15.7%
EPS 5Y-2.67%
EPS Q2Q%-3.03%
Revenue 1Y (TTM)-2.65%
Revenue growth 3Y1.62%
Revenue growth 5Y0.05%
Sales Q2Q%-2.1%

3.2 Future

PHIA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.22% yearly.
Based on estimates for the next years, PHIA will show a small growth in Revenue. The Revenue will grow by 3.86% on average per year.
EPS Next Y20.42%
EPS Next 2Y16.17%
EPS Next 3Y15.06%
EPS Next 5Y17.22%
Revenue Next Year-1.8%
Revenue Next 2Y1.14%
Revenue Next 3Y2.28%
Revenue Next 5Y3.86%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PHIA.AS Yearly Revenue VS EstimatesPHIA.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
PHIA.AS Yearly EPS VS EstimatesPHIA.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 19.85, PHIA is valued on the expensive side.
PHIA's Price/Earnings ratio is rather cheap when compared to the industry. PHIA is cheaper than 80.39% of the companies in the same industry.
PHIA is valuated rather cheaply when we compare the Price/Earnings ratio to 28.58, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 15.30 indicates a correct valuation of PHIA.
Based on the Price/Forward Earnings ratio, PHIA is valued a bit cheaper than the industry average as 74.51% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.47, PHIA is valued a bit cheaper.
Industry RankSector Rank
PE 19.85
Fwd PE 15.3
PHIA.AS Price Earnings VS Forward Price EarningsPHIA.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PHIA is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PHIA indicates a rather cheap valuation: PHIA is cheaper than 84.31% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 21.17
EV/EBITDA 30.71
PHIA.AS Per share dataPHIA.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PHIA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as PHIA's earnings are expected to grow with 15.06% in the coming years.
PEG (NY)0.97
PEG (5Y)N/A
EPS Next 2Y16.17%
EPS Next 3Y15.06%

More info and screens

5

5. Dividend

5.1 Amount

PHIA has a Yearly Dividend Yield of 4.15%, which is a nice return.
Compared to an average industry Dividend Yield of 2.50, PHIA pays a better dividend. On top of this PHIA pays more dividend than 98.04% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.28, PHIA pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.15%

5.2 History

The dividend of PHIA decreases each year by -65.46%.
Dividend Growth(5Y)-65.46%
Div Incr Years0
Div Non Decr Years0
PHIA.AS Yearly Dividends per sharePHIA.AS Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 2022 0.2 0.4 0.6 0.8

5.3 Sustainability

The earnings of PHIA are negative and hence is the payout ratio. PHIA will probably not be able to sustain this dividend level.
DP-0.48%
EPS Next 2Y16.17%
EPS Next 3Y15.06%
PHIA.AS Yearly Income VS Free CF VS DividendPHIA.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B -1B 2B 3B 4B

More info and screens

KONINKLIJKE PHILIPS NV

AMS:PHIA (1/24/2025, 7:00:00 PM)

25.61

-0.01 (-0.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-28 2024-10-28/bmo
Earnings (Next)02-03 2025-02-03/amc
Inst Owners47.12%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap24.07B
Analysts71.85
Price Target28.96 (13.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.15%
Yearly Dividend0
Dividend Growth(5Y)-65.46%
DP-0.48%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-10.06%
Min EPS beat(2)-13.15%
Max EPS beat(2)-6.96%
EPS beat(4)1
Avg EPS beat(4)-8.37%
Min EPS beat(4)-25.88%
Max EPS beat(4)12.53%
EPS beat(8)3
Avg EPS beat(8)19.85%
EPS beat(12)3
Avg EPS beat(12)2.62%
EPS beat(16)7
Avg EPS beat(16)5.54%
Revenue beat(2)0
Avg Revenue beat(2)-2.71%
Min Revenue beat(2)-2.95%
Max Revenue beat(2)-2.46%
Revenue beat(4)0
Avg Revenue beat(4)-3.39%
Min Revenue beat(4)-7.41%
Max Revenue beat(4)-0.75%
Revenue beat(8)2
Avg Revenue beat(8)-0.89%
Revenue beat(12)2
Avg Revenue beat(12)-1.44%
Revenue beat(16)2
Avg Revenue beat(16)-3.44%
PT rev (1m)0.2%
PT rev (3m)1.98%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.53%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.71%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.3%
Revenue NY rev (1m)-0.98%
Revenue NY rev (3m)-2.46%
Valuation
Industry RankSector Rank
PE 19.85
Fwd PE 15.3
P/S 1.33
P/FCF 21.17
P/OCF 13.37
P/B 2.03
P/tB N/A
EV/EBITDA 30.71
EPS(TTM)1.29
EY5.04%
EPS(NY)1.67
Fwd EY6.53%
FCF(TTM)1.21
FCFY4.72%
OCF(TTM)1.92
OCFY7.48%
SpS19.29
BVpS12.64
TBVpS-1.53
PEG (NY)0.97
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.43%
ROE -3.54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.56%
FCFM 6.27%
ROA(3y)1.3%
ROA(5y)2.5%
ROE(3y)2.33%
ROE(5y)5.25%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-40.52%
OM growth 5Y-26.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.47%
GM growth 5Y-1.32%
F-Score5
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 7.27
Debt/EBITDA 7.18
Cap/Depr 51.64%
Cap/Sales 3.66%
Interest Coverage N/A
Cash Conversion 181.09%
Profit Quality N/A
Current Ratio 1.16
Quick Ratio 0.74
Altman-Z 1.64
F-Score5
WACC6.03%
ROIC/WACCN/A
Cap/Depr(3y)53.02%
Cap/Depr(5y)58.22%
Cap/Sales(3y)4.17%
Cap/Sales(5y)4.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.65%
EPS 3Y-15.7%
EPS 5Y-2.67%
EPS Q2Q%-3.03%
EPS Next Y20.42%
EPS Next 2Y16.17%
EPS Next 3Y15.06%
EPS Next 5Y17.22%
Revenue 1Y (TTM)-2.65%
Revenue growth 3Y1.62%
Revenue growth 5Y0.05%
Sales Q2Q%-2.1%
Revenue Next Year-1.8%
Revenue Next 2Y1.14%
Revenue Next 3Y2.28%
Revenue Next 5Y3.86%
EBIT growth 1Y20.11%
EBIT growth 3Y-39.56%
EBIT growth 5Y-26.36%
EBIT Next Year69.31%
EBIT Next 3Y25.78%
EBIT Next 5YN/A
FCF growth 1Y-60.7%
FCF growth 3Y-2.55%
FCF growth 5Y0.39%
OCF growth 1Y-51.1%
OCF growth 3Y-5.06%
OCF growth 5Y-1.42%